- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04629066
Efficacy and Safety of ICD Remote Monitored Exercise Testing to Improve Heart Failure Outcomes: REMOTE HF-ACTION (x)
Efficacy and Safety of ICD Remote Monitored Exercise Testing to Improve Heart Failure Outcomes: REMOTE HF-ACTION (Pilot Randomized Controlled Trial)
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
North Carolina
-
Durham, North Carolina, United States, 27710
- Duke University Medical Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Patients have a MERLIN patient registry record for an ICD or CRT-D implantation between 01/01/2010-12/31/2020
- Age > 18 years
- Left ventricular ejection fraction < 50% by echocardiogram, nuclear cardiology scan, cardiac magnetic resonance imaging, or invasive left ventriculography within the past 12 months.
- Ongoing NYHA class II, III, or IV HF symptoms by questionnaire
- Ongoing use of beta-blocker and ACE-inhibitor or angiotensin receptor blocker or willingness to start them- assessed by Duke Epic EMR screening.
- Life expectancy > 12 months
- To allow for a post-surgical adjustment period, patients must be >30 days out from device implantation
Exclusion Criteria:
- Prior participation in CR- by patient questionnaire
- Unwillingness to sign informed consent form
- Currently performing > 240 minutes of device detected daily PA- by ICD/CRTD remotely collected data.
- Lack of a smartphone or unwillingness to use an App or Fitbit device
- Prior left ventricular assist device (LVAD) implantation or heart transplantation
- ICD tachyarrhythmia therapies programmed off
- Inherited arrhythmia condition with contraindication to exercise (eg Lamin A mutation or ARVC)
- No transmissions through Merlin.net in past 12 months
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
No Intervention: Usual care
Usual care will include regularly scheduled visits with the clinical heart failure care team and medical therapy as prescribed by that team.
|
|
Experimental: Remote prescription for aerobic exercise
The exercise prescription will be created by an exercise physiologist after incorporating remotely collected data from a patient directed smartphone app assessing HF symptom severity, vital signs, weight, and blood sugar, and cardiac implant measures of physical activity, heart rate, heart failure volume status and heart rhythm, and Fitbit measures of physical activity.
|
Patients randomized to remote CR will be asked to use an app for cardiac rehabilitation a minimum of 3 times a week. Patients will be given an exercise prescription provided by a certified exercise physiologist. The exercise prescription will change each week based on refreshed data from the prior week. Instructional videos for each exercise are provided in the app. Patients will not be told to perform the exercise at a particular time. Instead they will be asked to complete a certain amount of exercise per week at whatever time is convenient for them. Patients randomized to remote CR will also receive App based reminders to take their medications, resources to guide healthy eating habits, and other behavioral health advice as is done as standard of care in both remote based and clinic based CR. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Abbott Implantable Cardioverter-defibrillator (ICD) or Cardiac Resynchronization Therapy Defibrillator (CRT-D) Device Measured Daily Physical Activity (PA)
Time Frame: 12 weeks after randomization
|
Reported in minutes of PA per day.
|
12 weeks after randomization
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Number of Heart Failure Hospitalization, Fracture, Myocardial Infarction, Serious Adverse Arrhythmia, and ICD Therapy Combination Events
Time Frame: Cumulative during 12 weeks of intervention
|
Cumulative during 12 weeks of intervention
|
|
Kansas City Cardiomyopathy Questionnaire (KCCQ) Heart Failure (HF) Symptom Severity Score
Time Frame: 12 weeks after randomization
|
The KCCQ has a range of 0 to 100, where a higher score indicates a more favorable health status.
|
12 weeks after randomization
|
Change in Kansas City Cardiomyopathy Questionnaire (KCCQ) Heart Failure (HF) Symptoms Severity Score
Time Frame: Baseline to 12 weeks
|
The KCCQ has a range of 0 to 100, where a higher score indicates a more favorable health status.
|
Baseline to 12 weeks
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Brett Atwater, MD, Duke University
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Pro00107053
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Heart Failure
-
Tufts Medical CenterMetro West Medical CenterCompletedCongestive Heart Failure | Diastolic Heart Failure | Systolic Heart FailureUnited States
-
Abbott Medical DevicesCompletedHeart Failure | Heart Failure, Diastolic | Heart Failure, Systolic | Heart Failure NYHA Class II | Heart Failure NYHA Class III | Heart Failure With Reduced Ejection Fraction | Heart Failure NYHA Class IV | Heart Failure With Normal Ejection Fraction | Heart Failure; With Decompensation | Heart Failure...United States, Canada
-
Manipal UniversityUnknownHeart Failure | Decompensated Heart Failure | Acute Heart Failure | Diastolic Heart Failure | Systolic Heart FailureIndia
-
VA Eastern Colorado Health Care SystemNational Institute on Aging (NIA)CompletedHeart Failure | Heart Failure, Diastolic | Heart Failure, Systolic | Heart Failure With Reduced Ejection Fraction | Heart Failure With Preserved Ejection Fraction | Heart Failure; With Decompensation | Heart Failure,Congestive | Heart Failure AcuteUnited States
-
University Hospital, MontpellierCompletedHeart Failure | Diastolic Heart Failure | Systolic Heart Failure Stage CFrance
-
Wake Forest UniversityCompletedHeart Failure, Congestive | Heart Failure With Preserved Ejection Fraction
-
Lancaster General HospitalLouise von Hess Medical Research InstituteEnrolling by invitationDiastolic Heart FailureUnited States
-
Wake Forest UniversityNational Institute on Aging (NIA)CompletedHeart Failure, Congestive | Diastolic Heart FailureUnited States
-
Giresun UniversityIstanbul University - Cerrahpasa (IUC)RecruitingHeart Failure | Diastolic Heart Failure | Systolic Heart FailureTurkey
-
US Department of Veterans AffairsCompleted
Clinical Trials on Remote Cardiac Rehabilitation (CR)
-
Mayo ClinicRecruiting
-
Lawson Health Research InstituteHeart and Stroke Foundation of OntarioCompleted
-
Yousra Hisham Abdel FattahDiaa Mohamed Mohasseb; Mahmoud Mohamed Hassanein; Gihan Younis El-tantawi; Aya...CompletedMyocardial Infarction | Diabetes Mellitus, Type 2 | Diabetic Peripheral Neuropathy
-
Children's Mercy Hospital Kansas CityChildren's Hospital of Philadelphia; University of North Carolina, Chapel Hill and other collaboratorsRecruitingCongenital Heart Disease in ChildrenUnited States
-
Greater Manchester Mental Health NHS Foundation...University of Manchester; National Institute for Health Research, United Kingdom and other collaboratorsRecruitingHeart Failure | Heart Valve Diseases | Cardiomyopathies | Congenital Heart Disease | Cardiac Arrythmias | Cerebrovascular EventUnited Kingdom
-
Ottawa Heart Institute Research CorporationCompletedCoronary Heart Disease | Valve Disease, HeartCanada
-
University of MalagaRecruitingFrail Elderly Syndrome | Sarcopenia | Heart Failure With Preserved Ejection Fraction | Comorbidities and Coexisting ConditionsSpain
-
University of FlorenceUnknownCardiovascular DiseaseItaly
-
Umeå UniversityRecruitingHeart Defects, CongenitalSweden
-
St. Louis UniversityCompletedReferred by Cardiologist for Phase 2 Cardiac RehabilitationUnited States